Ataxia Diagnosis and Treatment Market Report (2022 to 2030) – GlaxoSmithKline…
<!-- Name:DistributionId Value:8752489 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Larimar
Larimar Therapeutics Announces Oral and Poster Presentations at the Upcoming…
BALA CYNWYD, Pa., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for…
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
BALA CYNWYD, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for…